baber/WOPTO huggingface dataset:
Patent AT-E332996-T1 (AT)
Inventor: LION JEAN-PIERRE
IPC: D06N3/00
Filed: 1999-09-08
Granted: 2006-08-15
Abstract: Flocks, already attached to the substrate, are lightly impregnated with polymer resin in aqueous emulsion in a bath. The material, thus impregnated, is dried. The resin attaches any loose flock fibers to the substrate. It limits ink penetration into the flock, in any subsequent printing stage. An Independent claim is included for the product of such manufacture. Preferred features: The resin content in the aqueous bath is preferably 2-12 dry wt%, especially 6-7%. Impregnation density is 100-150 g/m<2>. The resin is deposited in a moist environment on the flocked side only. Processes typically involve moistening, coating or atomization. Following impregnation, excess resin solution is wrung out using pressure rollers, which also even-out the deposit.
Patent AT-E275728-T1 (AT)
Inventor: KARUBE ISAO
IPC: G01N33/543
Filed: 1999-01-12
Granted: 2004-09-15
Abstract: A sensor chip for surface plasmon resonance which has a thin metal film, an antibody against a substance with the steroid skeleton such as a steroid hormone, a sex hormone or an environmental hormone (excluding triazine compounds), and a fixation layer for fixing the antibody to the thin metal film; and a method for detecting an environmental hormone which involves the step of exposing the antibody in the above-mentioned sensor chip to a sample, the step of irradiating the thin metal film with light and the step of determining the intensity of the light reflected by the thin metal film. This method achieves a high sensitivity and an excellent selectivity. <IMAGE>
Patent AT-E269103-T1 (AT)
Inventor: KAARSHOLM NIELS C
IPC: A61K38/26
Filed: 1999-03-08
Granted: 2004-07-15
Abstract: Aqueous compositions comprising at least one peptide selected from glucagon, GLP-1, and analogues and derivatives thereof together with a stabilizing and solubilizing amount of at least one detergent, said detergent having at least 2 positive charges, at least 2 negative charges, or a combination of at least one positive charge and at least one negative charge.
Patent AT-E345577-T1 (AT)
Inventor: SCHOEPP ALAN M
IPC: H05H1/46
Filed: 1999-03-26
Granted: 2006-12-15
Abstract: A plasma processing chamber includes a substrate holder and a member of silicon carbide such as a liner, focus ring, perforated baffle or a gas distribution plate, the member having an exposed surface adjacent the substrate holder and the exposed surface being effective to minimize contamination during processing of substrates. The chamber can include an antenna which inductively couples RF energy through the gas distribution plate to energize process gas into a plasma state.
Patent AT-E441434-T1 (AT)
Inventor: RAJAGOPALAN RAGHAVAN
IPC: G01N33/483
Filed: 1999-03-31
Granted: 2009-09-15
Abstract: A composition comprising non-covalent carrier-hapten bioconjugates having the formula HM-----CM wherein HM is a hapten molecule whose molecular weight is generally, but not always, less than 1000 Daltons and is capable of performing specific functions; CM is a carrier molecule, whose molecular weight is generally, but not always, more than 1000 Daltons and is capable of transporting the hapten to a specific site; and the dashed line is a non-covalent bond between the carrier molecule and the hapten molecule. The bioconjugates are formed from cyanine and carrier molecules such as methylated serum albumin, polyarginine, polyaspartic acid, polyglutamic acid, cyclodextrin, and inulin. The bioconjugates are useful in diagnostic and therapeutic medical procedures because they are stable in vitro before being used and stable in vivo during and after use.
Patent AT-E274344-T1 (AT)
Inventor: BEIMAN ELLIOTT
IPC: A61K9/22
Filed: 1999-06-25
Granted: 2004-09-15
Abstract: The present invention pertains to a sustained release drug delivery system which comprises a core of active ingredient, an enteric coating, a second coating of active ingredient and lastly a readily gastric-soluble protective coating. In another embodiment, the sustained release drug delivery system comprises a core of active ingredient, an enteric coating; a second coating of active ingredient; a second enteric coating and a third coating of active ingredient The sustained release dosage form of this invention is useful for pharmaceutically active ingredients that have limited aqueous solubility, especially phenytoin sodium, and other pH dependent soluble drugs.
Patent AT-E309540-T1 (AT)
Inventor: WILSON STUART MARK
IPC: G01N33/50
Filed: 1999-06-04
Granted: 2005-11-15
Abstract: The present invention relates to a method for detecting a target material in a sample, which method comprises the steps of: a) exposing a sample, expected to contain that target material, to at least two viruses which are capable of binding directly or indirectly with that target material so as to form a virally bound target material and to endow the virally bound target material with a distinctive property; and b) cultivating the product from stage a in the presence of an indicator material to which the viruses carried by the virally bound target material attach so as to cause the indicator material to adopt the distinctive property of the virally bound target material; and c) monitoring the presence or otherwise of virally attached indicator material. The invention also provides a kit for use in the method of the invention.
Patent AT-E251681-T1 (AT)
Inventor: TILLACK BERND
IPC: H01L21/285
Filed: 1999-09-20
Granted: 2003-10-15
Abstract: The invention aims to provide a method for producing an amorphous or polycrystalline layer on an insulating area which in relation to known methods increases the thickness of the amorphous or polycrystalline layer and improves the homogeneity of the deposition, thus resulting in reduced surface roughness while at least maintaining the insulating properties of the insulating area. To this end a suitable seeding layer (28, 29), preferably silicon nitride, is deposited so that the seeding capacity and insulating properties of the SiO2 insulating area (14, 31) during deposition of the amorphous or polycrystalline Si or SiGe layers (15, 16, 17, 33) are improved.
Patent AT-E265230-T1 (AT)
Inventor: AF URSIN KAIJA
IPC: A61K9/08
Filed: 1999-12-16
Granted: 2004-05-15
Abstract: Aqueous compositions of toremifene or a pharmaceutically acceptable salt thereof, comprising lactic acid, acetic acid, formic acid, methanesulfonic acid or the corresponding anion (lactate, acetate, formate or mesylate) as a solubility enhancing agent. Novel salts of toremifene with an acid selected from the group consisting of lactic acid, acetic acid, formic acid or methanesulfonic acid.
Patent AT-E261652-T1 (AT)
Inventor: VAN DEN BERG KAREL
IPC: A01K7/02
Filed: 1999-12-21
Granted: 2004-04-15
Abstract: An apparatus for providing consumables such as feed and water to animals, such as cows, which comprises a framework, on which a plurality of troughs are disposed, and a weighing device. The weighing device is provided with at least one weighing unit for selectively weighing the troughs and thus the amount of consumables in each trough. The weighing unit is movable around a central axis along a guide. A drive unit is provided for the weighing unit which may be a stepper motor. The weighing unit also includes a weighing sensor such as a load cell or a strain gauge. An identification sensor identifies the animal at the feeding trough and the weighing device is moved thereto which may weigh the trough to determine the amount of feed or water therein before the animal begins to eat or drink which is taken into account in metering further feed or water to the relevant trough. The weighing device may continue to weigh the feed or drink before, during and/or after the animal eats or drinks from the relevant trough. The amount and nature of the feed or drink or both which the animal receives in the trough is governed by the identification of the animal.
Patent DE-05820999-T1 (DE)
Title: Elektromechanische sexualstimulationsvorrichtung
Inventor: MURISON BRUCE
IPC: A61H19/00
Filed: 2005-12-19
Abstract: Vorrichtung zur Verwendung durch eine Frau für eine sexuelle Stimulierung oder ein Beckenbodentraining, umfassend einen inneren Arm, der bemessen ist, um in eine Vagina eingesetzt zu werden, um die Wand der Vagina am G-Punkt oder nahe diesem zu berühren, einen äußeren Arm, der bemessen ist, um die Klitoris zu berühren und ein biegsames U-förmiges Element, das den inneren und den äußeren Arm verbindet.
Patent DE-755283-T1 (DE)
Inventor: GOLDRATH MILTON
IPC: A61B18/04
Filed: 1995-04-11
Abstract: Apparatus for and method of recirculating fluid used in performing hysteroscopic endometrial ablation. The fluid preferably circulates through a closed loop, fluid delivery system, including a heater for heating the fluid, and passes through a chamber of known volume having graduated markings disposed thereon so that the amount of fluid circulating within the closed loop system can be continuously monitored. The apparatus is connected to the inlet and outlet ports of a hysteroscopic sheath positioned within the uterine cavity of a patient. Any drop of fluid level within the marked chamber will indicate to the surgeon that the patient is undesirably absorbing fluid so that the procedure may be swiftly terminated before adverse consequences occur.
Patent ES-2048711-T1 (ES)
Inventor: VIGNOLI JEAN-MARC
IPC: H02J7/34
Filed: 1990-04-24
Abstract: The device comprises a logic processing unit 14 powered, on the one hand, by the mains P, N and, on the other hand, by a battery 13 intended to replace the mains should the latter fail. The device comprises means 11 detecting a drop in mains voltage below a specified level, and means 12 for switching the battery into circuit. The logic processing unit 14 is designed such that, should the mains supply be interrupted for a long period, the battery is switched out of circuit, so as to avoid rapid running down of the battery, for example in the case where the interruption is by design. The commands given prior to the interruption in the mains supply can be stored, after checking, upon return of the mains supply. <IMAGE>
Patent ES-2044826-T1 (ES)
Title: Procedimiento de te\ido y producto te\ido.
Inventor: KAMATA MASAYASU
IPC: D06P1/00
Filed: 1991-08-29
Abstract: UN METODO PARA TINTAR QUE CONSISTE EN: UN PROCESO EN QUE SE TRATA UN PRODUCTO TEXTIL DE FIBRA DE CELULOSA CON UN COMPUESTO CATIONICO; Y OTRO PROCESO EN QUE SE TRATA EL PRODUCTO TEXTIL ASI TRATADO SUMERGIENDOLO EN UNA DISPERSION QUE CONTENGA PARTICULAS FINAS QUE PUEDEN CAMBIAR DE COLOR DE MANERA REVERSIBLE QUE COMPRENDE MATERIAL HERMOCROMICO O FOTOCROMICO EN UN COMPUESTO POLIMERICO ALTO.
Patent ES-2041618-T1 (ES)
Title: Metodo de desarrollar formas complejas de utiles.
IPC: B21D26/027
Filed: 1992-07-24
Abstract: SE PRESENTA UN METODO PARA DESARROLLAR EL CONTORNO DE HERRAMIENTAS DE CONFORMACION PARA FABRICAR MIEMBROS DE METAL DE FORMA COMPLEJA TALES COMO ALERONES Y PANELES PARA EL FUSELAJE DE UN AVION. SE REALIZA UNA SIMULACION POR ORDENADOR DEL PROCESO DE ENVEJECIMIENTO SOBRE UNA REPRESENTACION GEOMETRICA DE UN MIEMBRO QUE TENGA LAS PROPIEDADES DEL MATERIAL DE UN MIEMBRO METALICO DESEADO. EL PROCESO DE ENVEJECIMIENTO INCLUYE LOS PASOS DE: A) FORMAR UN MIEMBRO NO CONFORMADO EN UNA HERRAMIENTA QUE TENGA UN CONTORNO DE MENOR CURVATURA QUE EL CONTORNO DEL MIEMBRO DESEADO; B) CONSTREÑIR EL MIEMBRO NO FORMADO A LA CONDICION DE SOBREFORMADO; C) APLICAR UN CICLO DE ENVEJECIMIENTO TERMICO AL MIEMBRO; D) ENFRIAR EL MIEMBRO CONSTREÑIDO POSTERIORMENTE AL CICLO DE ENVEJECIMIENTO TERMICO; Y E) LIBERAR EL MIEMBRO CONSTREÑIDO DE LA CONDICION IMPARTIDA POR EL PASO B) Y PERMITIR QUE VUELVA DE NUEVO A UNA CONDICION DIMENSIONALMENTE ESTABLE QUE DEFINE EL MIEMBRO DESEADO QUE TIENE UN CONTORNO SUPERFICIAL DE FORMA COMPLEJA. A PARTIR DE LA SIMULACION, SE DETERMINA EL CONTORNO DE CURVATURA MENOR EN EL PASO A) PARA PRODUCIR EL MIEMBRO DE METAL DESEADO QUE SIGUE AL PASO E).
Patent CY-1107440-T1 (CY)
Inventor: CARTER CHRISTOPHER A
IPC: A61P35/02
Filed: 2006-12-21
Abstract: This invention relates to aryl urea compounds in combination with cytotoxic or cytostatic agents for use in treating raf kinase mediated diseases such as cancer.
Patent CY-1108883-T1 (CY)
Inventor: PAPADOPOULOS NICHOLAS J
IPC: A61K38/22
Filed: 2009-03-16
Abstract: Modified chimeric polypeptides with improved pharmacokinetics are disclosed useful for treating eye disorders, including age-related macular degeneration and diabetic retinopathy.
Patent CY-1109564-T1 (CY)
Title: Σταθεροποιημενα υπερκορεσμενα στερεα λιποφιλων φαρμακων
Inventor: FUNKE ADRIAN
IPC: A61K9/14
Filed: 2009-12-09
Abstract: Η παρούσα εφεύρεση αναφέρεται σε μία φαρμακολογική σύνθεση με βελτιωμένη διάλυση λιπόφιλων φαρμάκων σε ένα υδατικό μέσο. Έχει βρεθεί ότι φαρμακευτικές συνθέσεις που περιέχουν μία σκόνη λιπόφιλων ενώσεων, όπως ορμόνες και στεροειδή (π.χ. δροσπιρενόνη και βαλερική οιστραδιόλη), σε μοριακά διασπαρμένη μορφή μαζί με ένα φορέα που έχει ειδικό εμβαδόν επιφάνειας τουλάχιστον 250 m2/g, όπως διοξείδιο σίλικα, π.χ. διοξείδιο σίλικα που πωλείται με το όνομα Aeroperl®, έχουν βελτιωμένες ιδιότητες διάλυσης του λιπόφιλου φαρμάκου.
Patent CY-1112301-T1 (CY)
Inventor: YOW GREGORY D
IPC: A61J1/20
Filed: 2011-02-23
Abstract: A vented vial adapter for retaining aerosols when accessing a vial having a pierceable seal located over an opening of the vial, the adapter comprising: 
a flexible attachment device configured to engage the vial for secure mounting of the vial adapter to the vial; 
a cannula on the attachment device, the cannula having a sharpened tip configured to pierce the seal of the vial, a vent opening adjacent the sharpened tip, a slot, and a medicament opening on the slot, the vent opening leading to a vent lumen extending through the cannula, the medicament opening leading to a medicament lumen extending through the cannula; 
a body portion having a valve in fluid communication with the medicament lumen of the cannula, the valve biased to a closed orientation and configured to allow liquid to be introduced into and removed from the vial when the valve is actuated to an open orientation; and 
an elongate filter chamber having a first opening and a second opening, the first opening in fluid communication with the vent lumen of the cannula, the filter chamber containing a first filter device and a second filter device, the first filter device disposed between the first opening and the second filter device and configured to allow passage of liquid dispersed in gas to the second filter device while blocking non-dispersed liquid, the second filter device disposed between the first filter device and the second opening and configured to absorb liquid dispersed in gas.
Patent CY-1111810-T1 (CY)
Inventor: BAKSTAD EINAR
IPC: C07H17/04
Filed: 2011-09-05
Abstract: The present invention relates to methods of preparing anthocyanins, and methods of preparing precursors of anthocyanins. The methods utilize a coupling reaction between a sugar and a suitable electrophilic precursor to form Eastern half intermediates that are then reacted with Western half intermediates to form the target anthocyanins. Some Eastern half intermediates and electrophilic precursors also form part of the invention.
Patent CY-1112939-T1 (CY)
Inventor: SCHMIDT HARALD
IPC: B23K11/30
Filed: 2012-06-22
Abstract: The milling head for two point welding electrodes of a welding tong, where the welding electrode has a central area and a rotating flank, comprises an upper side, a lower side and two openings (50, 52), which combine the upper side and the lower side to each other. The upper side and the lower side have a flank cut (30) for the processing of flank of point welding electrode, and a central cut (36) for the processing of central area of the associated point welding electrode. Each passage partially limit the central cut and/or the flank cut. The milling head for two point welding electrodes of a welding tong, where the welding electrode has a central area and a rotating flank, comprises an upper side, a lower side and two openings (50, 52), which combine the upper side and the lower side to each other. The upper side and the lower side have a flank cut (30) for the processing of flank of point welding electrode, and a central cut (36) for the processing of central area of the associated point welding electrode. Each passage partially limit the central cut and/or the flank cut. Each single passage is limited only by the flank cut and/or only by the central cut of the top side or by the flank cut and/or the central cut of the lower side. The upper side and the lower side have flank cut and/or central cut. The central cut of the upper side and the central cut of the lower side are arranged on a cutter bar (34). The flank cut of the upper side continuously passes over in the central cut of the upper side, and the flank cut of the lower side continuously passes over in the central cut of the lower side. The cuts are rotation symmetrically arranged to 180[deg] . The milling head comprises two central cuts around 180[deg] . The cuts of the upper side and the lower side are identical in construction, where a milling insert (22) is formed in single-piece manner. The milling insert has a parallel displacement in the area of the cutter blade. The measure of the parallel displacement corresponds to the material thickness of the edge area of the milling insert.
Patent CY-1113290-T1 (CY)
Title: Μεθοδος για την ανιχνευση και διαγνωση καρκινου, η οποια περιλαμβανει εκκινητες και ανιχνευτες για την ειδικη ανιχνευση του δεικτη magε-a3
Inventor: COCHE THIERRY
IPC: C12Q1/68
Filed: 2012-10-02
Abstract: Η παρούσα εφεύρεση αφορά εκκινητές και ανιχνευτές ειδικούς για MAGE-A3 για χρήση σε νέα διαγνωστικά κιτ και μεθόδους. Η εφεύρεση αφορά επιπλέον ανοσοθεραπευτική αγωγή ειδικών πληθυσμών ασθενών που πάσχουν από καρκίνο, που υποφέρουν από όγκους, οι οποίοι εκφράζουν MAGE-A3.
Patent CY-1115415-T1 (CY)
Title: Πολυσωματιδια
Inventor: WALDEN MALCOLM
IPC: A61K31/385
Filed: 2014-07-31
Abstract: Πολυσωματίδια οξυκωδόνης μπορούν να κατασκευασθούν με εξώθηση μίγματος που περιέχει καταλλήλως (α) οξυξωδόνη,(β) αδιάλυτο στο νερό συμπολυμερές μεθακρυλικού αμμωνίου, (γ) πλαστικοποιητή, (δ) λιπαντικό και (ε) τροποποιητή υδατοδιαπερατότητας.
Patent CY-1115760-T1 (CY)
Title: Τικαγρελορη για την θεραπευτικη αγωγη ανευρυσματων κοιλιακης αορτης
Inventor: MICHEL JEAN-BAPTISTE
IPC: A61P9/10
Filed: 2014-10-30
Abstract: Η εφεύρεση παρέχει ενώσεις τριαζολο[4,5-d]πυριμιδίνης, που δρουν ως ανταγωνιστές του Ρ2T(Ρ2Υ12) υποδοχέα. Οι ενώσεις είναι χρήσιμες για τη θεραπευτική αγωγή ή πρόληψη ανευρυσμάτων κοιλιακής αορτής.
Patent CY-1116588-T1 (CY)
Title: Νεα παραγωγα 6,7-διϋποκατεστημενης-ισοκινολινης και η χρηση τους
Inventor: Takio Ville
IPC: C07D217/02
Filed: 2015-07-02
Abstract: Η παρούσα εφεύρεση αφορά σε ενώσεις του γενικού τύπου (1) και τα στερεοϊσομερή και τα φαρμακευτικά αποδεκτά άλατα και προφάρμακά τους, όπου το R' και τα R1- R5 είναι όπως ορίζονται στις αξιώσεις. Η εφεύρεση αφορά επίσης στις εν λόγω ενώσεις για χρήση ως φάρμακο και συγκεκριμένα στη θεραπεία του εθισμού στα ναρκωτικά και των σχετικών με το ΚΝΣ παθήσεων.
Patent CY-1123801-T1 (CY)
Title: Παραγωγα αρωματικου σουλφοναμιδιου
Inventor: WERNER STEFAN
IPC: C07D213/85
Filed: 2020-11-16
Abstract: Υποκατεστημένα αρωματικά σουλφοναμίδια του τύπου (Ι), φαρμακευτικές συνθέσεις και συνδυασμοί που περιλαμβάνουν τις εν λόγω ενώσεις και η χρήση των εν λόγω ενώσεων για την παραγωγή φαρμακευτικής σύνθεσης για την αγωγή ή προφύλαξη πάθησης.
Patent CY-1124288-T1 (CY)
Title: Cmv εμβολια
Inventor: ORLINGER KLAUS
IPC: C12N15/86
Filed: 2021-06-29
Abstract: Παρεχόμενοι στο παρόν είναι γενετικώς τροποποιημένοι αρενοϊικοί φορείς κατάλληλοι ως εμβόλια για αποτροπή και θεραπεία μολύνσεων και επανενεργοποίησης κυτταρομεγαλοϊού. Επίσης παρεχόμενες στο παρόν είναι φαρμακευτικές συνθέσεις και μέθοδοι για τη θεραπεία μολύνσεων και επανενεργοποίησης κυτταρομεγαλοϊού. Ειδικώς, παρεχόμενες στο παρόν είναι φαρμακευτικές συνθέσεις, εμβόλια και μέθοδοι θεραπείας μολύνσεων και επανενεργοποίησης κυτταρομεγαλοϊού.
Patent SI-1372956-T1 (SI)
Title: Use of ionomers for sealing insulating materials
Inventor: MOLL LOTHAR
IPC: B32B27/00
Filed: 2002-03-06
Abstract: In a method for sealing an insulating material for construction applications, the insulating material is sealed with a material sheet including an ionomer so as to provide a vapor retarder for the insulating material.
Patent SI-1431113-T1 (SI)
Title: Profiled part to hold and stiffen an overlapping section in a flat item
Inventor: STRIEFLER ARMIN
IPC: B60R13/01
Filed: 2003-12-05
Abstract: The preformed part (1) for the fixing and stiffening of a plate-form cut-out section in a flat product has a yoke element (4) which by its ends is connected to the flat section (2) of the preformed part via connecting members (12,13) which are sized and arranged so that in the region of the free ends of the cut length in the product they penetrate the cut and thereby pass through the product. The distance between the flat section and yoke element corresponds to the thickness of the product at these points and also the thickness of the product in the course of the hinge line around which the preformed part hinges.
Patent SI-1615908-T1 (SI)
Title: Basic salt of thioctic acid with l-carnitine
Inventor: SALVI ANNIBALE
IPC: A23L33/15
Filed: 2003-10-31
Abstract: Salt of thioctic acid with L-carnitine with the formula: <?in-line-formulae description="In-line Formulae" end="lead"?>AY(X)<SUB>x</SUB><?in-line-formulae description="In-line Formulae" end="tail"?> where A is where Y is the cation of an alkaline metal, of an alkaline earth metal or is a quaternary ammonium group, X is A or OH<SUP>-</SUP>, x is equal to 0 when Y is the cation of an alkaline metal or a quaternary ammonium group and equal to 1 when Y is an alkaline earth metal.
Patent SI-1809147-T1 (SI)
Title: Device for presenting bouquets of flowers
Inventor: CHARRIN PHILIPPE
IPC: A01G5/00
Filed: 2005-10-26
Abstract: The invention relates to a conical device for presenting individual bouquets of flowers, said device being characterised in that it comprises a regulatable closing system consisting of complementary (3) nesting male and female three-dimensional geometrical structures, the undercut outer side of the male three-dimensional geometrical structures (6) coming into contact with the undercut inner side of the female three-dimensional geometrical structures (7).
Patent SI-1713471-T1 (SI)
Title: Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
Inventor: MAUS JOACHIM
IPC: A61K9/00
Filed: 2005-01-24
Abstract: The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
Patent SI-2135878-T1 (SI)
Title: Tumor-associated peptide binding promiscuously to human leukocyte antigen (HLA) class II molecules
Inventor: DENGJEL JORN
IPC: A61K39/00
Filed: 2006-09-05
Abstract: The present invention relates to immunotherapeutic methods, and molecules and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides, that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the present invention relates to 49 novel peptide sequences derived from HLA class II molecules of human tumour cell lines which can be used in vaccine compositions for eliciting anti-tumour immune responses.